Gut bacteria pill could help shed pounds, new trial hopes

NCT ID NCT07507929

Not yet recruiting Disease control Sponsor: Wecare Probiotics Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a probiotic called Akkermansia muciniphila can help overweight and obese adults lose weight and improve their metabolism. Over 12 weeks, 76 participants will take either the probiotic or a placebo, while following a low-carb diet. Researchers will measure changes in body weight, body fat, and blood fats like cholesterol.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pasteurized Akkermansia muciniphila Akk11 probiotic capsules
What this could lead to: If it works, this could point toward a natural supplement to help with weight loss and better metabolic health in overweight adults.
What could go wrong: This is a small, early-stage trial with only 76 people. The probiotic may not cause significant weight loss, and results may not apply to everyone. No serious risks are expected, but digestive discomfort is possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY

Contacts and locations

Locations

The School of Food and Bioengineering, Henan University of Science and Technolog

Luoyang, Henan, 471000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.